Papayannopoulou T, Nakamoto B, Kurachi S, Tweeddale M, Messner H
Department of Medicine, University of Washington, Seattle 98195.
Blood. 1988 Sep;72(3):1029-38.
Detailed characterization of the composite phenotype of two newly established erythroleukemia lines (OCIM1, OCIM2) shows that these lines share many of their erythroid markers (ie, surface antigens and globin program) as well as several of their nonerythroid properties (myeloid/monocytic/megakaryocytic) with the two known erythroleukemia lines (K562, HEL). In addition, each displays novel and instructive features. We argue that the surface and globin phenotype of all erythroleukemia lines is nonrandom and that it may be of physiologic relevance; it could represent the most prevalent phenotype of cells transformed by leukemia in vivo, and it raises the possibility that cells with similar potentials exist transiently during normal hematopoietic differentiation before their irreversible commitment to a single lineage. As such, these cells demonstrate a greater phenotypic adaptability in vitro than do their single lineage-committed counterparts since they can differentiate toward more than one lineage.
对两个新建立的红白血病细胞系(OCIM1、OCIM2)的复合表型进行详细表征后发现,这些细胞系与两个已知的红白血病细胞系(K562、HEL)具有许多相同的红系标志物(即表面抗原和珠蛋白程序)以及一些非红系特性(髓系/单核细胞系/巨核细胞系)。此外,每个细胞系都表现出新颖且具有指导意义的特征。我们认为,所有红白血病细胞系的表面和珠蛋白表型并非随机,可能具有生理相关性;它可能代表了体内白血病转化细胞的最普遍表型,这也增加了一种可能性,即在正常造血分化过程中,具有相似潜能的细胞在不可逆地定向分化为单一细胞系之前会短暂存在。因此,这些细胞在体外表现出比其单一细胞系定向分化的对应细胞更强的表型适应性,因为它们可以向多个细胞系分化。